Answers are grounded in this paper and cite their sources.
The development of effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines has been a significant accomplishment. Adverse events are extremely rare, but continued surveillance is important, especially in at-risk populations. In 5 patients with preexisting immune dysregulation, hyperinflammatory syndromes, including hemophagocytic lymphohistiocytosis, developed after SARS-CoV-2 mRNA vaccination. Early recognition of this rare condition is essential.
No takes yet. Share an insight, caveat, or question.
Rocco et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: